Type 1 Diabetes Efficacy Studies

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

$0.49 - $7.00

Select Options

Studying CRS In A Diverse Population FAQS

$0.33 - $3.00

Select Options

GvHD Studies Graft vs Host Disease

$0.49 - $7.00

Select Options

Targeting Natural Killer Cell Activity With Humanized NSG IL15 Mouse Model

$0.33 - $3.00

Select Options

A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD

$0.96 - $9.00

Select Options

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

$0.84 - $9.00

Select Options

Preclinical Lupus Models and Studies

$0.49 - $7.00

Select Options

Imiquimod Induced Psoriasis Efficacy Studies

$0.49 - $7.00

Select Options